Minerva Neurosciences (NERV) Misses Q4 EPS by 153c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($0.56), $1.53 worse than the analyst estimate of $0.97.

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Jackson Financial Inc. (JXN) call put ratio 1 call to 14.6 puts with a focus on September 130 and 135 puts as share price down 4.8%
• iShares Silver Trust (SLV) call put ratio 2.6 calls to 1 put with a focus on October calls as share price up 4.4%